Kenneth A. Clark - 11 Oct 2024 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Director
Signature
/s/ Kenneth A. Clark
Issuer symbol
SMMT
Transactions as of
11 Oct 2024
Net transactions value
$0
Form type
4
Filing time
15 Oct 2024, 17:08:13 UTC
Previous filing
04 Jan 2024
Next filing
06 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +200,000 200,000 11 Oct 2024 Common Stock 200,000 $19.95 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on October 11, 2024. The shares underlying the option shall vest in four equal annual installments, subject to the reporting person continuing to serve as a member of the Strategic Advisory Committee of the Board, with the first installment occurring on October 11, 2025.
F2 Not applicable.